Literature DB >> 20797482

Dietary intake of S-(alpha-carboxybutyl)-DL-homocysteine induces hyperhomocysteinemia in rats.

Jana Strakova1, Kelly T Williams, Sapna Gupta, Kevin L Schalinske, Warren D Kruger, Rima Rozen, Jiri Jiracek, Lucas Li, Timothy A Garrow.   

Abstract

Betaine homocysteine S-methyltransferase (BHMT) catalyzes the transfer of a methyl group from betaine to homocysteine (Hcy), forming dimethylglycine and methionine. We previously showed that inhibiting BHMT in mice by intraperitoneal injection of S-(alpha-carboxybutyl)-DL-homocysteine (CBHcy) results in hyperhomocysteinemia. In the present study, CBHcy was fed to rats to determine whether it could be absorbed and cause hyperhomocysteinemia as observed in the intraperitoneal administration of the compound in mice. We hypothesized that dietary administered CBHcy will be absorbed and will result in the inhibition of BHMT and cause hyperhomocysteinemia. Rats were meal-fed every 8 hours an L-amino acid-defined diet either containing or devoid of CBHcy (5 mg per meal) for 3 days. The treatment decreased liver BHMT activity by 90% and had no effect on methionine synthase, methylenetetrahydrofolate reductase, phosphatidylethanolamine N-methyltransferase, and CTP:phosphocholine cytidylyltransferase activities. In contrast, cystathionine beta-synthase activity and immunodetectable protein decreased (56% and 26%, respectively) and glycine N-methyltransferase activity increased (52%) in CBHcy-treated rats. Liver S-adenosylmethionine levels decreased by 25% in CBHcy-treated rats, and S-adenosylhomocysteine levels did not change. Furthermore, plasma choline decreased (22%) and plasma betaine increased (15-fold) in CBHcy-treated rats. The treatment had no effect on global DNA and CpG island methylation, liver histology, and plasma markers of liver damage. We conclude that CBHcy-mediated BHMT inhibition causes an elevation in total plasma Hcy that is not normalized by the folate-dependent conversion of Hcy to methionine. Furthermore, metabolic changes caused by BHMT inhibition affect cystathionine beta-synthase and glycine N-methyltransferase activities, which further deteriorate plasma Hcy levels. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20797482      PMCID: PMC2929918          DOI: 10.1016/j.nutres.2010.06.017

Source DB:  PubMed          Journal:  Nutr Res        ISSN: 0271-5317            Impact factor:   3.315


  52 in total

1.  Early-onset ischaemic stroke: analysis of 58 polymorphisms in 17 genes involved in methionine metabolism.

Authors:  Betti Giusti; Claudia Saracini; Paola Bolli; Alberto Magi; Ida Martinelli; Flora Peyvandi; Maurizia Rasura; Massimo Volpe; Luca A Lotta; Speranza Rubattu; Pier Mannuccio Mannucci; Rosanna Abbate
Journal:  Thromb Haemost       Date:  2010-05-10       Impact factor: 5.249

2.  CTP: phosphocholine cytidylyltransferase from rat liver.

Authors:  D E Vance; S D Pelech; P C Choy
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

3.  Regulation of hepatic betaine-homocysteine methyltransferase by dietary betaine.

Authors:  J D Finkelstein; J J Martin; B J Harris; W E Kyle
Journal:  J Nutr       Date:  1983-03       Impact factor: 4.798

4.  Regulation of hepatic betaine-homocysteine methyltransferase by dietary methionine.

Authors:  J D Finkelstein; B J Harris; J J Martin; W E Kyle
Journal:  Biochem Biophys Res Commun       Date:  1982-09-16       Impact factor: 3.575

5.  Triiodothyronine treatment attenuates the induction of hepatic glycine N-methyltransferase by retinoic acid and elevates plasma homocysteine concentrations in rats.

Authors:  Kelly A Tanghe; Tim A Garrow; Kevin L Schalinske
Journal:  J Nutr       Date:  2004-11       Impact factor: 4.798

6.  Relative contributions of sulfur atoms of dietary cysteine and methionine to rat liver glutathione and proteins.

Authors:  N Tateishi; T Higashi; A Naruse; K Hikita; Y Sakamoto
Journal:  J Biochem       Date:  1981-12       Impact factor: 3.387

7.  Glycine N-methyltransferase is a folate binding protein of rat liver cytosol.

Authors:  R J Cook; C Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  The L-methionine-sparing effect of dietary glutathione in rats.

Authors:  N Tateishi; M Hirasawa; T Higashi; Y Sakamoto
Journal:  J Nutr       Date:  1982-12       Impact factor: 4.798

9.  Retinoic acid and glucocorticoid treatment induce hepatic glycine N-methyltransferase and lower plasma homocysteine concentrations in rats and rat hepatoma cells.

Authors:  Matthew J Rowling; Kevin L Schalinske
Journal:  J Nutr       Date:  2003-11       Impact factor: 4.798

10.  Perturbations in homocysteine-linked redox homeostasis in a murine model for hyperhomocysteinemia.

Authors:  Victor Vitvitsky; Sanjana Dayal; Sally Stabler; You Zhou; Hong Wang; Steven R Lentz; Ruma Banerjee
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-03-11       Impact factor: 3.619

View more
  9 in total

Review 1.  Homocysteine imbalance: a pathological metabolic marker.

Authors:  Kevin L Schalinske; Anne L Smazal
Journal:  Adv Nutr       Date:  2012-11-01       Impact factor: 8.701

2.  Homocysteinemia in mice with genetic betaine homocysteine S-methyltransferase deficiency is independent of dietary folate intake.

Authors:  Ya-Wen Teng; Ignacio Cerdena; Steven H Zeisel
Journal:  J Nutr       Date:  2012-09-26       Impact factor: 4.798

3.  Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas.

Authors:  Ya-Wen Teng; Mihai G Mehedint; Timothy A Garrow; Steven H Zeisel
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

4.  Inhibition of betaine-homocysteine S-methyltransferase in rats causes hyperhomocysteinemia and reduces liver cystathionine β-synthase activity and methylation capacity.

Authors:  Jana Strakova; Sapna Gupta; Warren D Kruger; Ryan N Dilger; Katherine Tryon; Lucas Li; Timothy A Garrow
Journal:  Nutr Res       Date:  2011-07       Impact factor: 3.315

5.  Plasma lipids and betaine are related in an acute coronary syndrome cohort.

Authors:  Michael Lever; Peter M George; Wendy Atkinson; Sarah L Molyneux; Jane L Elmslie; Sandy Slow; A Mark Richards; Stephen T Chambers
Journal:  PLoS One       Date:  2011-07-01       Impact factor: 3.240

6.  The contrasting relationships between betaine and homocysteine in two clinical cohorts are associated with plasma lipids and drug treatments.

Authors:  Michael Lever; Peter M George; Wendy Atkinson; Jane L Elmslie; Sandy Slow; Sarah L Molyneux; Richard W Troughton; A Mark Richards; Christopher M Frampton; Stephen T Chambers
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

7.  Betaine and secondary events in an acute coronary syndrome cohort.

Authors:  Michael Lever; Peter M George; Jane L Elmslie; Wendy Atkinson; Sandy Slow; Sarah L Molyneux; Richard W Troughton; A Mark Richards; Christopher M Frampton; Stephen T Chambers
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

8.  Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study.

Authors:  Michael Lever; Sandy Slow; David O McGregor; Warwick J Dellow; Peter M George; Stephen T Chambers
Journal:  Cardiovasc Diabetol       Date:  2012-07-11       Impact factor: 9.951

Review 9.  Lean Body Mass Harbors Sensing Mechanisms that Allow Safeguarding of Methionine Homeostasis.

Authors:  Yves Ingenbleek
Journal:  Nutrients       Date:  2017-09-20       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.